Posts Tagged ‘Elias Campo’

Tuesday January 28th, 2014

Dr. Elías Campo receives the 2013 Catalan National Research Award

The Government of Catalonia and the Fundació Catalana per a la Recerca i la Innovació recognize through the 2013 National Research Awards the excellence in research activity of scientists. The awards want to encourage the social recognition of science and, particularly, to spread among the Catalan society the work of its researchers. These awards are the highest honour in research in Catalonia. The President of the Catalan Government, Artur Mas, underlined last night during the ceremony that “the path achieved in research, science and technology transfer” will allow the country, over the next ten years, “to talk face to face with the leading countries of the world”. This year’s winners were: Elías Campo, National Research Award; Isabelle Anguelovski, National Research Award to Young Talent; KIC InnoEnergy Iberia, National Award in Public- Private Partnership in Research and Innovation; José Carreras Foundation, National Award for scientific Sponsorship; and, Ara newspaper, National Award for Science Communication.

Information via: www.fundaciorecerca.cat

Comments Closed
Wednesday December 11th, 2013

Dr. Elias Campo among the Catalan university system researchers awarded by ICREA Academia

The Catalan Government and the Institució Catalana de Recerca i Estudis Avançats (ICREA), presented the list of 24 researchers from the Catalan research system awarded with ICREA Academia distinctions. Among them is Dr. Elías Campo, head of the IDIBAPS Human and experimental functional oncomorphology, Director of Research at Hospital Clínic of Barcelona and at the Fundació Clinic, who has also been recently announced as the new Catalan National Research Award winner. The ICREA Academia awards, which celebrate its V edition, recognize the research work of teaching staff in a Catalan public university while, at the same time, helps to retain research talent within the Catalan university system. The award, which includes a 50,000 euros grant, involves a preferent dedication to research during 5 years.

information via www.govern.cat

Comments Closed
Monday November 25th, 2013

Dr. Elías Campo awarded with the the Premi Nacional de Recerca (Catalan National Award for Research)

Dr. Elías Campo is one of the most prominent researchers at IDIBAPS and Professor of Pathology at the University of Barcelona. He combines the positions of director of research at the Hospital Clínic of Barcelona and director of the Clínic Foundation with his work as head of the IDIBAPS research team Human and experimental functional oncomorphology. Investigations he led as co- director of the Spanish Consortium for the chronic lymphocytic leukemia Genome have provided valuable information on the genetics and treatment of this leukemia, the most common in Western countries. Today has been announced that the Catalan Foundation for Research and Innovation, with support from the Government of Catalonia, has recognized his work with the Premi Nacional de Recerca (Catalan National Award for Research), the highest award of Catalan science. The statement announcing the award highlights that “his research has identified cells that cause leukemia, discovered new molecular mechanisms involved in its development and improved its diagnosis.”

Read the rest of this entry »

Comments Closed
Tuesday October 22nd, 2013

The genome of one of the most aggressive lymphomas has been sequenced

Mantle cell lymphoma is a very aggressive and difficult to treat cancer originated in blood cells and lymph nodes. To identify the molecular alterations responsible for this tumor, and facilitate the development of new treatments, a team of scientists led by Dr. Xose S. Puente and Dr. Carlos López-Otín, at University of Oviedo, and Dr. Sílvia Beà and Dr. Elias Campo, at IDIBAPS, Hospital Clínic, University of Barcelona, have sequenced the genomes of over 30 of lymphomas. The result of this work, published today in the prestigious U.S. journal Proceedings of the National Academy of Sciences (PNAS), presents the first comprehensive genomic analysis of this disease. “The study provides insight into causes and evolution of this complex neoplasm and has identified targets for new treatments“, says Dr. Silvia Beà, first author of the study.

Read the rest of this entry »

Comments Closed

Categories

Posted in:

Friday May 10th, 2013

Prof. Reiner Siebert presents the genomic profiling and sequence analysis of B-cell lymphomas

Prof. Reiner Siebert is a Human Geneticist pioneering the genomic profiling and sequence analysis of B-cell lymphomas at the Institute of Human Genetics of the Christian-Albrechts-Universität zu Kiel (Germany). He was invited by Dr. Elías Campo, head of the Human and experimental functional oncomorphology IDIBAPS team and Director of Research at the Hospital Clínic of Barcelona, to offer an IDIBAPS Seminar held on May 6th. Dr. Iñaki Martín – Subero, investigator from Dr. Campo’s team and a former student at Prof. Siebert’s laboratory, introduced this crowded seminar.

Read the rest of this entry »

Comments Closed
Monday March 18th, 2013

Spanish Consortium for the Study of the Genome of the Chronic Lymphatic Leukemia, co-led by Dr. Elías Campo, links for the first time cancer with errors in the protection of chromosomes

A research published by Nature Genetics explores a new mechanism that may contribute to the development of diverse tumors, including chronic lymphatic leukemia, a form of cancer that affects thousands of new patients each year in Spain. The researchers have detected for the first time in a human cancer the mutation of an essential gene for the protection of the telomeres, situated on the edges of the chromosomes. The research, directed by Carlos López-Otín, of the University Institute of Oncology of the University of Oviedo, Elías Campo, of the Clínic Hospital/University of Barcelona, and María Blasco, director of the National Center of Oncological Research (CNIO), breaks new ground for the Spanish Consortium for the Study of the Genome of the Chronic Lymphatic Leukemia.

Read the rest of this entry »

Comments Closed
 Page 1 of 3  1  2  3 »